669 related articles for article (PubMed ID: 9202001)
1. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
Franklin CC; Kraft AS
J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
3. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis.
Franklin CC; Srikanth S; Kraft AS
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3014-9. PubMed ID: 9501207
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity.
Laderoute KR; Mendonca HL; Calaoagan JM; Knapp AM; Giaccia AJ; Stork PJ
J Biol Chem; 1999 Apr; 274(18):12890-7. PubMed ID: 10212278
[TBL] [Abstract][Full Text] [Related]
5. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.
Chu Y; Solski PA; Khosravi-Far R; Der CJ; Kelly K
J Biol Chem; 1996 Mar; 271(11):6497-501. PubMed ID: 8626452
[TBL] [Abstract][Full Text] [Related]
6. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways.
Li C; Hu Y; Mayr M; Xu Q
J Biol Chem; 1999 Sep; 274(36):25273-80. PubMed ID: 10464250
[TBL] [Abstract][Full Text] [Related]
7. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
8. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
Biggs JR; Ahn NG; Kraft AS
Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
[TBL] [Abstract][Full Text] [Related]
11. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.
Tanoue T; Moriguchi T; Nishida E
J Biol Chem; 1999 Jul; 274(28):19949-56. PubMed ID: 10391943
[TBL] [Abstract][Full Text] [Related]
13. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells.
Schliess F; Heinrich S; Häussinger D
Arch Biochem Biophys; 1998 Mar; 351(1):35-40. PubMed ID: 9500841
[TBL] [Abstract][Full Text] [Related]
14. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation.
Liu Y; Gorospe M; Yang C; Holbrook NJ
J Biol Chem; 1995 Apr; 270(15):8377-80. PubMed ID: 7721728
[TBL] [Abstract][Full Text] [Related]
15. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.
Hömme M; Schmitt CP; Mehls O; Schaefer F
J Am Soc Nephrol; 2004 Nov; 15(11):2844-50. PubMed ID: 15504937
[TBL] [Abstract][Full Text] [Related]
17. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.
Muda M; Theodosiou A; Rodrigues N; Boschert U; Camps M; Gillieron C; Davies K; Ashworth A; Arkinstall S
J Biol Chem; 1996 Nov; 271(44):27205-8. PubMed ID: 8910287
[TBL] [Abstract][Full Text] [Related]
18. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
Camps M; Nichols A; Gillieron C; Antonsson B; Muda M; Chabert C; Boschert U; Arkinstall S
Science; 1998 May; 280(5367):1262-5. PubMed ID: 9596579
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.
Bokemeyer D; Lindemann M; Kramer HJ
Hypertension; 1998 Oct; 32(4):661-7. PubMed ID: 9774360
[TBL] [Abstract][Full Text] [Related]
20. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation.
Begum N; Ragolia L
Am J Physiol Cell Physiol; 2000 Jan; 278(1):C81-91. PubMed ID: 10644515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
